首页> 外文OA文献 >Effects on rabbit nodal, atrial, ventricular and Purkinje cell potentials of a new antiarrhythmic drug, cibenzoline, which protects against action potential shortening in hypoxia.
【2h】

Effects on rabbit nodal, atrial, ventricular and Purkinje cell potentials of a new antiarrhythmic drug, cibenzoline, which protects against action potential shortening in hypoxia.

机译:一种新的抗心律不齐药物cibenzoline对兔淋巴结,房性,心室和Purkinje细胞电位的影响,可防止缺氧时动作电位的缩短。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

1 The effects of cibenzoline (UP 339-01), a new anti-arrhythmic drug, have been investigated in various cardiac tissues. 2 UP 339-01 produced a bradycardia, due partly to prolongation of the intracellularly recorded sinus node action potential duration (APD) and partly to depression of the maximum rate of depolarization (MRD). The slope of the slow diastolic depolarization was not significantly reduced. 3 UP 339-01 was not a beta-adrenoceptor antagonist. 4 UP 339-01 was negatively inotropic, and shifted the relation between [Ca2+]o and force of contractions to the right, and increased A-H conduction time. It was concluded that UP 339-01 restricted slow inward current. 5 In all cardiac tissues depolarized by fast inward current, UP 339-01 caused a reduction in MRD and conduction velocity. The reduction was similar in atrial muscle, His and terminal Purkinje fibres, but in papillary muscle the effect was about half as great. On desheathed frog nerve UP 339-01 had a local anaesthetic potency slightly greater than that of procaine. 6 APD was significantly prolonged in a dose-related manner in ventricular muscle but to a lesser extent in the bundle of His and atrial tissue. In terminal Purkinje fibres APD50 and APD90 were unaltered, but the transient outward current ("notch') was abolished, resulting in a lengthening of APD20. 7 The effective and functional refractory periods of the A-V node and right bundle branch were both lengthened by UP 339-01 in a dose-related manner, and the difference between them was greatly increased. 8 UP 339-01 (2.63 microM) completely prevented the shortening of APD90 induced by hypoxia, and the shortening of APD50 and APD20 was much attenuated. There was no protection against hypoxic depression of contractions. 9 It was concluded that UP 339-01 is a highly active class 1 anti-arrhythmic agent with additional class 3 and 4 properties.
机译:1已经在各种心脏组织中研究了一种新的抗心律不齐药物cibenzoline(UP 339-01)的作用。 2 UP 339-01产生心动过缓,部分原因是细胞内记录的窦房结动作电位持续时间(APD)延长,部分原因是最大去极化率(MRD)降低。缓慢舒张期去极化的斜率没有明显降低。 3 UP 339-01不是β-肾上腺素受体拮抗剂。 4 UP 339-01为负性变力,使[Ca2 +] o与收缩力之间的关系向右移动,并增加了A-H传导时间。结论是,UP 339-01限制了缓慢的内向电流。 5在所有通过快速向内电流去极化的心脏组织中,UP 339-01导致MRD和传导速度降低。心房肌,His和末节浦肯野纤维的减少相似,但乳头肌的减少约一半。在干燥的青蛙神经上,UP 339-01的局部麻醉药效力比普鲁卡因略强。 6 APD以剂量相关的方式在心室肌中显着延长,但在His和心房组织束中的程度较小。在末端浦肯野光纤中,APD50和APD90的纤维未变,但瞬态向外电流(“缺口”)被消除,导致APD20延长。7UP延长了AV结和右束支的有效不应期339-01呈剂量相关性,两者之间的差异大大增加; 8 UP 339-01(2.63 microM)完全阻止了缺氧引起的APD90的缩短,而APD50和APD20的缩短被大大减弱。 9得出结论,UP 339-01是一种高活性的1类抗心律不齐药物,具有3类和4类其他特性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号